Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2015, Banyan Pacific Capital operates from locations including Hong Kong, Beijing, Shanghai, Shenzhen, and Silicon Valley. The firm manages an investment scale nearing $8 billion and employs a dual model of fund-of-funds and direct investment. It focuses on international investments in technology and life sciences.
Banyan Pacific Capital primarily invests in the technology and life sciences sectors. In technology, it targets artificial intelligence, big data, intelligent manufacturing, and SaaS. The life sciences focus includes innovative drugs, medical devices, and in vitro diagnostics.
Notable investments include 海思盖德 (Haisegai), which specializes in innovative medical devices for micro-invasive glaucoma surgery, and 方圆食里 (Waysia), a fresh food e-commerce platform that has recently secured funding to expand its operations.
Email your pitch deck to bpc@banyanpac.com for consideration.
Yes, Banyan Pacific Capital often leads investment rounds, particularly in its focus sectors of technology and life sciences.
The firm actively participates in follow-on investments to support portfolio companies as they grow and scale.
Banyan Pacific Capital manages a fund size of approximately $8 billion, allowing for significant investments across various stages.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.